Xylem Inc.
Congress has disclosed 12 buys and 6 sells of XYL (Xylem Inc.) in official financial disclosures, each linked to its original filing. A transparency record — not investment advice.
Activity Congressional Activity
Round-trip watch Still on the books
Members who disclosed buying XYL and have not disclosed selling, versus their own entry (the most recent disclosed buy). "Open" means no disclosed sale — never "still holds" — and the % is unrealised, on paper. Not investment advice.
| Member | Entry (last buy) | Entry price | Now | vs entry | Status |
|---|---|---|---|---|---|
| Rohit Khanna | 2026-07-07 | $120.19 | $94.04 | -21.8% | underwater |
Price as of 2026-11-02. Counted open while disclosed buys outnumber disclosed sells; tracks the price, not exact position size (amounts are ranges).
Fundamentals · FY2026 Valuation
Standard valuation multiples from SEC-reported GAAP financials (trailing twelve months), each compared to the median for —. We use reported GAAP, not forward or adjusted earnings, so our figures can sit higher than sites that do — especially for companies with falling profit. Relative context — not a target price or investment advice.
how it's calculated
how it's calculated
how it's calculated
18 trades Recent Congressional Trades
Two things to watch per trade: the disclosure lag (how many days passed before the trade was made public) and the price move in that window (how the stock moved during those non-public days). A sell followed by a price drop, or a buy followed by a rise, means well-timed trading — visible here in the open. Note: the Score measures how notable a trade is, not whether it made money — the price move is shown for context and isn't part of it.
| Politician | Chamber | Type | Owner | Date | Disclosure lag | Price move in that window | Amount | Score | Source |
|---|---|---|---|---|---|---|---|---|---|
| Rohit Khanna | House | BUY OCR | Child | 2026-07-07 | 27 days | -1.3% | $1K–$15K | 27.3 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider convergence · moderate | Child | 2026-06-02 | 29 days | +6.3% | $1K–$15K | 19.9 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider convergence · moderate | Child | 2026-05-01 | 38 days | -4.7% | $1K–$15K | 19.9 | ↗ filing |
| Rohit Khanna | House | SELL OCR ◆ insider convergence | Child | 2025-06-06 | 31 days | +3.4% | $15K–$50K | 48.0 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence · moderate | Child | 2024-02-02 | 32 days | — | $1K–$15K | 40.4 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence | Child | 2023-11-03 | 32 days | — | $15K–$50K | 90.9 | ↗ filing |
| Susie Lee | House | SELL | Joint · DSL Living Trust > Bank of New York Brokerage Account 340 | 2022-11-30 | 5 days | — | $1K–$15K 0.2% of NW |
8.6 | ↗ filing |
| Katherine Clark | House | SELL | Spouse | 2021-06-04 | 70 days | — | $1K–$15K 0.1% of NW |
40.4 | ↗ filing |
| Katherine Clark | House | BUY | Spouse | 2020-11-05 | 53 days | — | $1K–$15K 0.1% of NW |
75.9 | ↗ filing |
| Susie Lee | House | SELL | Joint | 2020-10-19 | 13 days | — | $1K–$15K 0.2% of NW |
10.6 | ↗ filing |
| Susie Lee | House | BUY | Joint | 2019-07-12 | 19 days | — | $1K–$15K 0.2% of NW |
15.7 | ↗ filing |
| Susie Lee | House | BUY | Joint | 2019-06-25 | 5 days | — | $1K–$15K 0.2% of NW |
22.3 | ↗ filing |
| Susie Lee | House | BUY | Joint | 2019-04-25 | 6 days | — | $1K–$15K 0.2% of NW |
40.4 | ↗ filing |
| Susie Lee | House | BUY | Joint | 2019-04-12 | 19 days | — | $1K–$15K 0.2% of NW |
75.9 | ↗ filing |
| Jackie Speier | House | SELL | Self | 2018-07-30 | 1 days | — | $1K–$15K | 92.2 | ↗ filing |
| Suzan DelBene | House | SELL | Joint | 2016-06-09 | 0 days | — | $50K–$100K 0.1% of NW |
53.5 | ↗ filing |
| Suzan DelBene | House | BUY | Joint | 2015-07-27 | 0 days | — | $15K–$50K <0.1% of NW |
56.6 | ↗ filing |
| Suzan DelBene | House | BUY | Joint | 2014-10-10 | 25 days | — | $15K–$50K <0.1% of NW |
90.9 | ↗ filing |
Corporate insiders · SEC Form 4 Insider Activity
What the company's own officers and directors did in XYL — open-market purchases and sales from SEC Form 4 filings (option exercises, grants and tax withholding are excluded). This is context for the congressional activity above, never a buy/sell signal, and the two datasets are kept separate on purpose. Does convergence mean anything? →
Of the congressional trades in XYL, 3 coincided with corporate insiders moving the same way within 60 days, and 2 with insiders moving the opposite way. This is co-occurrence only — whether it carries any edge is tested honestly on the convergence page.
| Date | Insider | Role | Type | Size | Source |
|---|---|---|---|---|---|
| 2026-10-29 | KOCH D CHRISTIAN | Director | BUY | $986K | ↗ EDGAR |
| 2026-05-07 | McShane Geri-Michelle | Other | SELL | $501K | ↗ EDGAR |
| 2026-05-04 | Peribere Jerome A | Director | BUY | $141K | ↗ EDGAR |
| 2025-11-04 | Harker Victoria D | Director | SELL | $252K | ↗ EDGAR |
| 2025-10-30 | Toussaint Claudia S | Other | SELL | $1.6M | ↗ EDGAR |
| 2025-09-05 | McShane Geri-Michelle | Other | SELL | $140K | ↗ EDGAR |
| 2025-08-18 | Glatch Lisa | Director | SELL | $689K | ↗ EDGAR |
| 2025-08-04 | Harker Victoria D | Director | SELL | $259K | ↗ EDGAR |
| 2025-03-07 | McShane Geri-Michelle | Other | SELL | $528K | ↗ EDGAR |
| 2025-03-04 | Capers Dorothy Trefon | Other | SELL | $1.5M | ↗ EDGAR |
| 2024-11-01 | Tretikov Lila | Director | SELL | $480 | ↗ EDGAR |
| 2024-10-22 | Tretikov Lila | Director | BUY | $528 | ↗ EDGAR |
| 2024-09-09 | Harker Victoria D | Director | SELL | $352K | ↗ EDGAR |
| 2024-06-10 | McShane Geri-Michelle | Other | SELL | $316K | ↗ EDGAR |
| 2024-06-05 | Aulick Rodney | C-suite | SELL | $3.0M | ↗ EDGAR |
| 2024-03-05 | Yarkadas Hayati | C-suite | SELL | $580K | ↗ EDGAR |
| 2024-03-01 | Cerwinka Franz | Other | SELL | $171K | ↗ EDGAR |
| 2024-03-01 | Yarkadas Hayati | C-suite | SELL | $1.2M | ↗ EDGAR |
| 2024-03-01 | Yarkadas Hayati | C-suite | SELL | $640K | ↗ EDGAR |
| 2024-03-01 | Yarkadas Hayati | C-suite | SELL | $619K | ↗ EDGAR |
| 2024-03-01 | Yarkadas Hayati | C-suite | SELL | $620K | ↗ EDGAR |
| 2024-02-20 | McShane Geri-Michelle | Other | SELL | $123K | ↗ EDGAR |
| 2024-02-15 | Beliveau-Dunn Jeanne | Director | SELL | $228K | ↗ EDGAR |
| 2024-02-14 | Aulick Rodney | C-suite | SELL | $2.9M | ↗ EDGAR |
| 2024-02-08 | Toussaint Claudia S | Other | SELL | $1.1M | ↗ EDGAR |
Combined timeline — Congress & insiders
Both sets of trades on one timeline, newest first, so you can see when they lined up. Congress vs ◆ insider.
| Date | Who | Type | Size | |
|---|---|---|---|---|
| ◆ insider | 2026-10-29 | KOCH D CHRISTIAN Director | BUY | $986K |
| Congress | 2026-07-07 | Rohit Khanna | BUY | $1K–$15K |
| Congress | 2026-06-02 | Rohit Khanna | BUY | $1K–$15K |
| ◆ insider | 2026-05-07 | McShane Geri-Michelle Other | SELL | $501K |
| ◆ insider | 2026-05-04 | Peribere Jerome A Director | BUY | $141K |
| Congress | 2026-05-01 | Rohit Khanna | BUY | $1K–$15K |
| ◆ insider | 2025-11-04 | Harker Victoria D Director | SELL | $252K |
| ◆ insider | 2025-10-30 | Toussaint Claudia S Other | SELL | $1.6M |
| ◆ insider | 2025-09-05 | McShane Geri-Michelle Other | SELL | $140K |
| ◆ insider | 2025-08-18 | Glatch Lisa Director | SELL | $689K |
| ◆ insider | 2025-08-04 | Harker Victoria D Director | SELL | $259K |
| Congress | 2025-06-06 | Rohit Khanna | SELL | $15K–$50K |
| ◆ insider | 2025-03-07 | McShane Geri-Michelle Other | SELL | $528K |
| ◆ insider | 2025-03-04 | Capers Dorothy Trefon Other | SELL | $1.5M |
| ◆ insider | 2024-11-01 | Tretikov Lila Director | SELL | $480 |
| ◆ insider | 2024-10-22 | Tretikov Lila Director | BUY | $528 |
| ◆ insider | 2024-09-09 | Harker Victoria D Director | SELL | $352K |
| ◆ insider | 2024-06-10 | McShane Geri-Michelle Other | SELL | $316K |
| ◆ insider | 2024-06-05 | Aulick Rodney C-suite | SELL | $3.0M |
| ◆ insider | 2024-03-05 | Yarkadas Hayati C-suite | SELL | $580K |
| ◆ insider | 2024-03-01 | Cerwinka Franz Other | SELL | $171K |
| ◆ insider | 2024-03-01 | Yarkadas Hayati C-suite | SELL | $1.2M |
| ◆ insider | 2024-03-01 | Yarkadas Hayati C-suite | SELL | $640K |
| ◆ insider | 2024-03-01 | Yarkadas Hayati C-suite | SELL | $619K |
FAQ Common questions
How much has Congress traded XYL?
12 disclosed buys and 6 sells of XYL (Xylem Inc.) appear in official congressional financial disclosures.
Is it legal for members of Congress to trade XYL?
Members of Congress may trade stocks but must disclose it under the STOCK Act. QuantCapitol tracks those public disclosures for transparency — nothing here is an accusation of wrongdoing or investment advice.
Where does this data come from?
Official US House Clerk and Senate electronic financial disclosures. Every trade links back to its original filing so you can verify it yourself.